Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.

Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Dienel A, Schläfke S.

Wien Med Wochenschr. 2010 Dec;160(21-22):547-56. doi: 10.1007/s10354-010-0845-7. Review.

PMID:
21170695
2.

A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.

Woelk H, Schläfke S.

Phytomedicine. 2010 Feb;17(2):94-9. doi: 10.1016/j.phymed.2009.10.006. Epub 2009 Dec 3.

PMID:
19962288
3.

Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial.

Kasper S, Anghelescu I, Dienel A.

Eur Neuropsychopharmacol. 2015 Nov;25(11):1960-7. doi: 10.1016/j.euroneuro.2015.07.024. Epub 2015 Aug 7.

PMID:
26293583
4.

An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.

Kasper S.

Int J Psychiatry Clin Pract. 2013 Nov;17 Suppl 1:15-22. doi: 10.3109/13651501.2013.813555. Epub 2013 Aug 3. Review.

PMID:
23808618
5.

Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial.

Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Dienel A, Schläfke S.

Int Clin Psychopharmacol. 2010 Sep;25(5):277-87. doi: 10.1097/YIC.0b013e32833b3242.

PMID:
20512042
6.

Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.

Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Schläfke S, Dienel A.

Int J Neuropsychopharmacol. 2014 Jun;17(6):859-69. doi: 10.1017/S1461145714000017. Epub 2014 Jan 23.

PMID:
24456909
7.

Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trial.

Kasper S, Volz HP, Dienel A, Schläfke S.

Eur Neuropsychopharmacol. 2016 Feb;26(2):331-340. doi: 10.1016/j.euroneuro.2015.12.002. Epub 2015 Dec 12.

PMID:
26718792
8.

Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.

Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S.

Eur Arch Psychiatry Clin Neurosci. 2017 Nov 17. doi: 10.1007/s00406-017-0852-4. [Epub ahead of print]

PMID:
29150713
9.

Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder.

Uehleke B, Schaper S, Dienel A, Schlaefke S, Stange R.

Phytomedicine. 2012 Jun 15;19(8-9):665-71. doi: 10.1016/j.phymed.2012.02.020. Epub 2012 Apr 3.

PMID:
22475718
10.

A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.

Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.

J Clin Psychopharmacol. 1993 Dec;13(6):429-37.

PMID:
7907097
11.

Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.

Kasper S.

Wien Med Wochenschr. 2015 Jun;165(11-12):217-28. doi: 10.1007/s10354-015-0360-y. Epub 2015 Jun 20.

PMID:
26092515
12.
13.

No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.

Heger-Mahn D, Pabst G, Dienel A, Schläfke S, Klipping C.

Drugs R D. 2014 Dec;14(4):265-72. doi: 10.1007/s40268-014-0065-5.

14.

Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial.

Herrera-Arellano A, Jiménez-Ferrer JE, Zamilpa A, García-Alonso G, Herrera-Alvarez S, Tortoriello J.

Planta Med. 2012 Sep;78(14):1529-35. Epub 2012 Jul 24.

PMID:
22828921
15.

Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.

Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J.

Planta Med. 2007 Jul;73(8):713-7. Epub 2007 Jun 11.

PMID:
17562493
16.

Silexan in anxiety disorders: Clinical data and pharmacological background.

Kasper S, Müller WE, Volz HP, Möller HJ, Koch E, Dienel A.

World J Biol Psychiatry. 2017 Jun 19:1-9. doi: 10.1080/15622975.2017.1331046. [Epub ahead of print]

PMID:
28511598
17.

Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set.

Kasper S, Möller HJ, Volz HP, Schläfke S, Dienel A.

Int Clin Psychopharmacol. 2017 Jul;32(4):195-204. doi: 10.1097/YIC.0000000000000176.

PMID:
28379882
19.

Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder.

Feltner DE, Harness J, Brock J, Sambunaris A, Cappelleri JC, Morlock R.

CNS Neurosci Ther. 2009 Winter;15(1):12-8. doi: 10.1111/j.1755-5949.2008.00075.x.

PMID:
19228175
20.

Supplemental Content

Support Center